E-cigarettes and Urologic Health: A Collaborative Review of Toxicology, Epidemiology, and Potential Risks

European Urology

Volumn 71, Issue 6, 2017, Pages 915-923

  Bourke, Liam ^a   Bauld, Linda ^b   Bullen, Christopher ^c   Cumberbatch, Marcus ^d   Giovannucci, Edward ^e   Islami, Farhad ^f   McRobbie, Hayden ^g   Silverman, Debra T ^h   Catto, James W F ^d  

^a SHEFFIELD HALLAM UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF STIRLING   (United Kingdom)

^c UNIVERSITY OF AUCKLAND   (New Zealand)

^d UNIVERSITY OF SHEFFIELD   (United Kingdom)

^e HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^f AMERICAN CANCER SOCIETY   (United States)

^g QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^h NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Electronic cigarettes; Smoking cessation; Toxicology; Urologic health

Indexed keywords

HEAVY METAL; NITROSAMINE; POLYCYCLIC AROMATIC HYDROCARBON; NICOTINE; NICOTINIC AGENT;

CLINICAL PRACTICE; CLINICAL TRIAL; DEMOGRAPHY; ELECTRONIC CIGARETTE; HEALTH CARE POLICY; HEALTH HAZARD; HUMAN; PRIORITY JOURNAL; PUBLIC HEALTH; REVIEW; SMOKING CESSATION; UROGENITAL SYSTEM; ADOLESCENT; ADULT; AGED; ANIMAL; CHEMICALLY INDUCED; CHILD; DEVICES; FEMALE; INHALATIONAL DRUG ADMINISTRATION; MALE; MIDDLE AGED; PREVALENCE; PROCEDURES; PRODUCT SAFETY; RISK ASSESSMENT; RISK FACTOR; SMOKING; URINARY TRACT DISEASE; VAPING; YOUNG ADULT;

ADMINISTRATION, INHALATION; ADOLESCENT; ADULT; AGED; ANIMALS; CHILD; CONSUMER PRODUCT SAFETY; ELECTRONIC NICOTINE DELIVERY SYSTEMS; FEMALE; HUMANS; MALE; MIDDLE AGED; NICOTINE; NICOTINIC AGONISTS; PREVALENCE; RISK ASSESSMENT; RISK FACTORS; SMOKING; SMOKING CESSATION; UROLOGIC DISEASES; VAPING; YOUNG ADULT;

EID: 85009286602     PISSN: 03022838     EISSN: 18737560     Source Type: Journal    
DOI: 10.1016/j.eururo.2016.12.022     Document Type: Review

References (79)

1. [1] Purdue, M.P., Silverman, D.T., Clearing the air: summarizing the smoking-related relative risks of bladder and kidney cancer. Eur Urol 70 (2016), 467–468.
2. [2] Yeh, J.S., Bullen, C., Glantz, S.A., Clinical decisions. E-cigarettes and smoking cessation. N Engl J Med 374 (2016), 2172–2174.
3. [3] Action on Smoking and Health, Fact sheet. On the use of electronic cigarettes among adults in Great Britain. 2015, ASH UK, London, UK.
4. [4] Yan, X.S., D'Ruiz, C., Effects of using electronic cigarettes on nicotine delivery and cardiovascular function in comparison with regular cigarettes. Regul Toxicol Pharmacol 71 (2015), 24–34.
5. [5] Etter, J.-F., Bullen, C., Electronic cigarette: users profile, utilization, satisfaction and perceived efficacy. Addiction 106 (2011), 2017–2028.
6. [6] Dawkins, L., Turner, J., Roberts, A., Soar, K., ‘Vaping’ profiles and preferences: an online survey of electronic cigarette users. Addiction 108 (2013), 1115–1125.
7. [7] Leigh, N.J., Lawton, R.I., Hershberger, P.A., Goniewicz, M.L., Flavourings significantly affect inhalation toxicity of aerosol generated from electronic nicotine delivery systems (ENDS). Tob Control 25 (2016), ii81–ii87.
8. [8] Behar, R.Z., Luo, W., Lin, S.C., et al. Distribution, quantification and toxicity of cinnamaldehyde in electronic cigarette refill fluids and aerosols. Tob Control 25 (2016), ii94–ii102.
9. [9] Kreiss, K., Gomaa, A., Kullman, G., Fedan, K., Simoes, E.J., Enright, P.L., Clinical bronchiolitis obliterans in workers at a microwave-popcorn plant. N Engl J Med 347 (2002), 330–338.
10. [10] Goniewicz, M.L., Hajek, P., McRobbie, H., Nicotine content of electronic cigarettes, its release in vapour and its consistency across batches: regulatory implications. Addiction 109 (2014), 500–507.
11. [11] Hua, M., Yip, H., Talbot, P., Mining data on usage of electronic nicotine delivery systems (ENDS) from YouTube videos. Tobacco Control 22 (2013), 103–106.
12. [12] Filippidis, F.T., Laverty, A.A., Gerovasili, V., Vardavas, C.I., Two-year trends and predictors of e-cigarette use in 27 European Union member states. Tob Control 26 (2017), 98–104.
13. [13] Vardavas, C.I., Filippidis, F.T., Agaku, I.T., Determinants and prevalence of e-cigarette use throughout the European Union: a secondary analysis of 26 566 youth and adults from 27 Countries. Tobacco control. 24 (2015), 442–448.
14. [14] Eastwood, B., Dockrell, M.J., Arnott, D., et al. Electronic cigarette use in young people in Great Britain 2013-2014. Public Health 129 (2015), 1150–1156.
15. [15] Czoli, C.D., Reid, J.L., Rynard, V.L., Hammond, D., Tobacco use in Canada: patterns and trends, 2015 edition. Special supplement: E-cigarettes in Canada. Waterloo. 2015, Propel Centre for Population Health Impact, University of Waterloo, Canada.
16. [16] Hu, S.S., Neff, L., Agaku, I.T., et al. Tobacco product use among adults—United States, 2013-2014. Morb Mortal Wkly Rep 65 (2016), 685–691.
17. [17] Singh, T., Arrazola, R.A., Corey, C.G., et al. Tobacco use among middle and high school students—United States, 2011-2015. Morb Mortal Wkly Rep 65 (2016), 361–367.
18. [18] US Public Health Service. E-cigarette use among youth and young adults: a report of the Surgeon General. http://e-cigarettes.surgeongeneral.gov/documents/2016_SGR_Full_Report_non-508.pdf.
19. [19] Jiang, N., Chen, J., Wang, M.P., et al. Electronic cigarette awareness and use among adults in Hong Kong. Addict Behav 52 (2016), 34–38.
20. [20] Li, J., Newcombe, R., Walton, D., The prevalence, correlates and reasons for using electronic cigarettes among New Zealand adults. Addict Behav 45 (2015), 245–251.
21. [21] Lee, S., Grana, R.A., Glantz, S.A., Electronic cigarette use among Korean adolescents: a cross-sectional study of market penetration, dual use, and relationship to quit attempts and former smoking. J Adolesc Health 54 (2014), 684–690.
22. [22] Palipudi, K.M., Mbulo, L., Morton, J., et al. Awareness and current use of electronic cigarettes in Indonesia, Malaysia, Qatar, and Greece: findings from 2011-2013 global adult tobacco surveys. Nicotine Tob Res 18 (2016), 501–507.
23. [23] Beard, E., West, R., Michie, S., Brown, J., Association between electronic cigarette use and changes in quit attempts, success of quit attempts, use of smoking cessation pharmacotherapy, and use of stop smoking services in England: time series analysis of population trends. Br Med J, 354, 2016, i4645.
24. [24] Bunnell, R.E., Agaku, I.T., Arrazola, R.A., et al. Intentions to smoke cigarettes among never-smoking US middle and high school electronic cigarette users: National Youth Tobacco Survey, 2011-2013. Nicotine Tob Res 17 (2015), 228–235.
25. [25] Leventhal, A.M., Strong, D.R., Kirkpatrick, M.G., et al. Association of electronic cigarette use with initiation of combustible tobacco product smoking in early adolescence. JAMA 314 (2015), 700–707.
26. [26] McMillen, R.C., Gottlieb, M.A., Shaefer, R.M., Winickoff, J.P., Klein, J.D., Trends in electronic cigarette use among U.S. adults: use is increasing in both smokers and nonsmokers. Nicotine Tob Res 17 (2015), 1195–1202.
27. [27] Wang, M.P., Ho, S.Y., Leung, L.T., Lam, T.H., Electronic cigarette use and its association with smoking in Hong Kong Chinese adolescents. Addict Behav 50 (2015), 124–127.
28. [28] Barrington-Trimis, J.L., Urman, R., Leventhal, A.M., et al. E-cigarettes, cigarettes, and the prevalence of adolescent tobacco use. Pediatrics, 138, 2016, e20153983.
29. [29] Farsalinos, K.E., Poulas, K., Voudris, V., Le Houezec, J., Electronic cigarette use in the European Union: analysis of a representative sample of 27 460 Europeans from 28 countries. Addiction 111 (2016), 2032–2040.
30. [30] The Editors, Reviews: making sense of an often tangled skein of evidence. Ann Intern Med 142 (2005), 1019–1020.
31. [31] Manzoli, L., La Vecchia, C., Flacco, M.E., et al. Multicentric cohort study on the long-term efficacy and safety of electronic cigarettes: study design and methodology. BMC Public Health, 13, 2013, 883.
32. [32] Orellana-Barrios, M.A., Payne, D., Mulkey, Z., Nugent, K., Electronic cigarettes—a narrative review for clinicians. Am J Med 128 (2015), 674–681.
33. [33] Cumberbatch, M.G., Rota, M., Catto, J.W., La Vecchia, C., The role of tobacco smoke in bladder and kidney carcinogenesis: a comparison of exposures and meta-analysis of incidence and mortality risks. Eur Urol 70 (2015), 458–466.
34. [34] Byun DJ, Cohn MR, Patel SN, Donin NM, Sosnowski R, Bjurlin MA. The effect of smoking on 30-day complications following radical prostatectomy. Clin Genitourin Cancer. In press. http://dx.doi.org/10.1016/j.clgc.2016.08.002.
35. [35] Kotandeniya, D., Carmella, S.G., Pillsbury, M.E., Hecht, S.S., Combined analysis of N′-nitrosonornicotine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in the urine of cigarette smokers and e-cigarette users. J Chromatogr B Analyt Technol Biomed Life Sci 1007 (2015), 121–126.
36. [36] Hecht, S.S., Carmella, S.G., Kotandeniya, D., et al. Evaluation of toxicant and carcinogen metabolites in the urine of e-cigarette users versus cigarette smokers. Nicotine Tob Res 17 (2015), 704–709.
37. [37] Martinez-Sanchez, J.M., Fu, M., Martin-Sanchez, J.C., Ballbe, M., Salto, E., Fernandez, E., Perception of electronic cigarettes in the general population: does their usefulness outweigh their risks?. BMJ Open, 5, 2015, e009218.
38. [38] Jensen, R.P., Luo, W., Pankow, J.F., Strongin, R.M., Peyton, D.H., Hidden formaldehyde in e-cigarette aerosols. N Engl J Med 372 (2015), 392–394.
39. [39] Farsalinos, K.E., Voudris, V., Poulas, K., E-cigarettes generate high levels of aldehydes only in ‘dry puff’ conditions. Addiction 110 (2015), 1352–1356.
40. [40] Nitzkin, J.L., Farsalinos, K., Siegel, M., More on hidden formaldehyde in e-cigarette aerosols. N Engl J Med, 372, 2015, 1575.
41. [41] Hua, M., Talbot, P., Potential health effects of electronic cigarettes: a systematic review of case reports. Prev Med Rep 4 (2016), 169–178.
42. [42] Allen, J.G., Flanigan, S.S., LeBlanc, M., et al. Flavoring chemicals in e-cigarettes: diacetyl, 2,3-pentanedione, and acetoin in a sample of 51 products, including fruit-, candy-, and cocktail-flavored e-cigarettes. Environ Health Perspect 124 (2016), 733–739.
43. [43] Cheng, T., Chemical evaluation of electronic cigarettes. Tob Control 23:Suppl 2 (2014), ii11–ii17.
44. [44] Cumberbatch, M.G., Cox, A., Teare, D., Catto, J.W., Contemporary occupational carcinogen exposure and bladder cancer: a systematic review and meta-analysis. JAMA Oncol 1 (2015), 1282–1290.
45. [45] Yuge, K., Kikuchi, E., Hagiwara, M., et al. Nicotine induces tumor growth and chemoresistance through activation of the PI3K/Akt/mTOR pathway in bladder cancer. Mol Cancer Ther 14 (2015), 2112–2120.
46. [46] Baan, R., Grosse, Y., Straif, K., et al. A review of human carcinogens— part F: chemical agents and related occupations. Lancet Oncol 10 (2009), 1143–1144.
47. [47] Silverman, D.T., Devesa, S.S., Moore, L.E., Rothman, N., Bladder cancer. Schottenfeld, D., Fraumeni, J.F. Jr., (eds.) Cancer epidemiology and prevention, ed. 3, 2006, Oxford University Press, New York, NY.
48. [48] Pisinger, C., Dossing, M., A systematic review of health effects of electronic cigarettes. Prev Med 69 (2014), 248–260.
49. [49] Boffetta, P., Fontana, L., Stewart, P., et al. Occupational exposure to arsenic, cadmium, chromium, lead and nickel, and renal cell carcinoma: a case-control study from Central and Eastern Europe. Occup Environ Med 68 (2011), 723–728.
50. [50] Liao, L.M., Friesen, M.C., Xiang, Y.B., et al. Occupational lead exposure and associations with selected cancers: the Shanghai Men's and Women's Health Study cohorts. Environ Health Perspect 124 (2016), 97–103.
51. [51] Williams, M., Villarreal, A., Bozhilov, K., Lin, S., Talbot, P., Metal and silicate particles including nanoparticles are present in electronic cigarette cartomizer fluid and aerosol. PLoS One, 8, 2013, e57987.
52. [52] Yu, V., Rahimy, M., Korrapati, A., et al. Electronic cigarettes induce DNA strand breaks and cell death independently of nicotine in cell lines. Oral Oncol 52 (2016), 58–65.
53. [53] Pacifici, R., Altieri, I., Gandini, L., et al. Nicotine, cotinine, and trans-3-hydroxycotinine levels in seminal plasma of smokers: effects on sperm parameters. Ther Drug Monit 15 (1993), 358–363.
54. [54] Saaranen, M., Kantola, M., Saarikoski, S., Vanha-Perttula, T., Human seminal plasma cadmium: comparison with fertility and smoking habits. Andrologia 21 (1989), 140–145.
55. [55] Golli, N.E., Jrad-Lamine, A., Neffati, H., et al. Impact of e-cigarette refill liquid exposure on rat kidney. Regul Toxicol Pharmacol 77 (2016), 109–116.
56. [56] Polosa, R., Caponnetto, P., Morjaria, J.B., Papale, G., Campagna, D., Russo, C., Effect of an electronic nicotine delivery device (e-cigarette) on smoking reduction and cessation: a prospective 6-month pilot study. BMC Public Health, 11, 2011, 786.
57. [57] Polosa, R., Morjaria, J.B., Caponnetto, P., et al. Effectiveness and tolerability of electronic cigarette in real-life: a 24-month prospective observational study. Intern Emerg Med 9 (2014), 37–46.
58. [58] Caponnetto, P., Auditore, R., Russo, C., Cappello, G.C., Polosa, R., Impact of an electronic cigarette on smoking reduction and cessation in schizophrenic smokers: a prospective 12-month pilot study. Int J Environ Res Public Health 10 (2013), 446–461.
59. [59] Pacifici, R., Pichini, S., Graziano, S., Pellegrini, M., Massaro, G., Beatrice, F., Successful nicotine intake in medical assisted use of e-cigarettes: a pilot study. Int J Environ Res Public Health 12 (2015), 7638–7646.
60. [60] Polosa, R., Caponnetto, P., Maglia, M., Morjaria, J.B., Russo, C., Success rates with nicotine personal vaporizers: a prospective 6-month pilot study of smokers not intending to quit. BMC Public Health, 14, 2014, 1159.
61. [61] Polosa, R., Caponnetto, P., Cibella, F., Le-Houezec, J., Quit and smoking reduction rates in vape shop consumers: a prospective 12-month survey. Int J Environ Res Public Health 12 (2015), 3428–3438.
62. [62] Hajek, P., Corbin, L., Ladmore, D., Spearing, E., Adding e-cigarettes to specialist stop-smoking treatment: City of London pilot project. J Addiction Res Ther, 6, 2015, 244.
63. [63] Borderud, S.P., Li, Y., Burkhalter, J.E., Sheffer, C.E., Ostroff, J.S., Electronic cigarette use among patients with cancer: characteristics of electronic cigarette users and their smoking cessation outcomes. Cancer 120 (2014), 3527–3535.
64. [64] Bullen, C., Howe, C., Laugesen, M., et al. Electronic cigarettes for smoking cessation: a randomised controlled trial. Lancet 382 (2013), 1629–1637.
65. [65] Caponnetto, P., Campagna, D., Cibella, F., et al. Efficiency and safety of an electronic cigarette (ECLAT) as tobacco cigarettes substitute: a prospective 12-month randomized control design study. PLoS One, 8, 2013, e66317.
66. [66] Adriaens, K., Van Gucht, D., Declerck, P., Baeyens, F., Effectiveness of the electronic cigarette: an eight-week Flemish study with six-month follow-up on smoking reduction, craving and experienced benefits and complaints. Int J Environ Res Public Health 11 (2014), 11220–11248.
67. [67] Hartmann-Boyce, J., McRobbie, H., Bullen, C., Begh, R., Stead, L.F., Hajek, P., Electronic cigarettes for smoking cessation. Cochrane Database Syst Rev, 2016, 2016, CD010216.
68. [68] Rahman, M.A., Hann, N., Wilson, A., Mnatzaganian, G., Worrall-Carter, L., E-cigarettes and smoking cessation: evidence from a systematic review and meta-analysis. PLoS One, 10, 2015, e0122544.
69. [69] Khoudigian, S., Devji, T., Lytvyn, L., Campbell, K., Hopkins, R., O'Reilly, D., The efficacy and short-term effects of electronic cigarettes as a method for smoking cessation: a systematic review and a meta-analysis. Int J Public Health 61 (2016), 257–267.
70. [70] Kalkhoran, S., Glantz, S.A., E-cigarettes and smoking cessation in real-world and clinical settings: a systematic review and meta-analysis. Lancet Respir Med 4 (2016), 116–128.
71. [71] Farsalinos, K.E., Poulas, K., Voudris, V., Le Houezec, J., Electronic cigarette use in the European Union: analysis of a representative sample of 27 460 Europeans from 28 countries. Addiction (Abingdon, England), 2016.
72. [72] West, R., Shahab, L., Brown, J., Estimating the population impact of e-cigarettes on smoking cessation in England. Addiction 111 (2016), 1118–1119.
73. [73] Royal College of Physicians. Nicotine without smoke: tobacco harm reduction. www.rcplondon.ac.uk/projects/outputs/nicotine-without-smoke-tobacco-harm-reduction-0.
74. [74] Rose, A., Filion, K.B., Eisenberg, M.J., Franck, C., Electronic cigarettes: a comparison of national regulatory approaches. Can J Public Health 106 (2015), e450–e453.
75. [75] European Commission. Revision of the Tobacco Products Directive. http://ec.europa.eu/health/tobacco/products/revision/index_en.htm.
76. [76] Medicines and Healthcare Products Regulatory Agency. e-Voke 10 mg electronic inhaler, PL42601/0003 e-Voke 15 mg electronic inhaler PL42601/004. www.mhra.gov.uk/home/groups/par/documents/websiteresources/con475307.pdf.
77. [77] Munafo, M., What a drag. New Sci. 229 (2016), 28–29.
78. [78] Adkison, S.E., O'Connor, R.J., Bansal-Travers, M., et al. Electronic nicotine delivery systems: international tobacco control four-country survey. Am J Prev Med 44 (2013), 207–215.
79. [79] Etter, J.F., Bullen, C., Flouris, A.D., Laugesen, M., Eissenberg, T., Electronic nicotine delivery systems: a research agenda. Tob Control 20 (2011), 243–248.